Pharmacogenomics Journal

SJR Rank #7,430H-index: 101SJR: 0.760Best quartile: Q2APC: US$4,890
Journal website: aims, scope and author guidelines
Publisher

Springer Nature

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • GeneticsQ2
  • Molecular MedicineQ2
  • PharmacologyQ2

Areas: Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Pharmacogenetics and Drug MetabolismDrug Transport and Resistance MechanismsGenetic Associations and EpidemiologyPharmacological Effects and Toxicity StudiesColorectal Cancer Treatments and StudiesReceptor Mechanisms and SignalingComputational Drug Discovery MethodsAcute Lymphoblastic Leukemia researchNeurotransmitter Receptor Influence on BehaviorGenomics and Rare Diseases

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0306090120

Documents per Year

20222025015304560

Detailed Information

ISSN

1470-269X, 1473-1150

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

2.58

References per Document

42.62

Coverage

2001-2026

Scope

The Pharmacogenomics Journal is a print and electronic journal, which is dedicated to the rapid publication of original research on pharmacogenomics and its clinical applications. Key areas of coverage include: Personalized medicine Effects of genetic variability on drug toxicity and efficacy Identification and functional characterization of polymorphisms relevant to drug action Pharmacodynamic and pharmacokinetic variations and drug efficacy Integration of new developments in the genome project and proteomics into clinical medicine, pharmacology, and therapeutics Clinical applications of genomic science Identification of novel genomic targets for drug development Potential benefits of pharmacogenomics.

Metrics from SCImago Journal Rank 2025. View on SCImago